A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Immune Response Following Administration of Zoster Vaccine to Subjects With Rheumatoid Arthritis Receiving Tofacitinib (CP-690,550) Or Placebo With Background Methotrexate Treatment
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Tofacitinib (Primary) ; Varicella zoster virus vaccine
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Pfizer
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism.
- 03 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 18 Sep 2014 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Mar 2015 to 1 Apr 2015.